Caris Life Sciences

Caris Life Sciences Caris Life Sciences delivers technologies to revolutionize healthcare with market-leading profiling

Caris Life Sciences® is the leading next-generation TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial intelligence (AI) and machine learning al

gorithms, Caris has created the large-scale, clinico-genomic database and computing capability needed to analyze and unravel the molecular complexity of disease. This convergence of sequencing power, big data and AI technologies provides an unmatched platform to deliver the next-generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection and drug development.

Caris Life Sciences announced that the University of New Mexico Comprehensive Cancer Center has joined the Caris Precisi...
08/07/2026

Caris Life Sciences announced that the University of New Mexico Comprehensive Cancer Center has joined the Caris Precision Oncology Alliance® (Caris POA), a global network of leading cancer centers, academic institutions, research organizations and healthcare systems focused on advancing precision oncology and biomarker-driven research.

“Together, we will leverage molecular science, clinical expertise and real-world evidence to generate insights that help improve outcomes for patients facing cancer,” said James Hamrick, MD, MPH, Chairman of the Caris Precision Oncology Alliance.

Learn more: https://ow.ly/k4CH50Zxkwb

What if you could know before cancer changes everything? Early detection has the potential to change lives. That's why C...
08/06/2026

What if you could know before cancer changes everything?

Early detection has the potential to change lives. That's why Caris Detect™ was designed to be the most advanced multi-cancer early detection (MCED) test ever created.

Unlike approaches that analyze only a fraction of your genetic information, Caris Detect analyzes all of your DNA and RNA, looking for cancer-associated molecular signals in the blood—often before symptoms appear.

If you have a family history of cancer or are concerned about your personal risk, Caris Detect can help you take a more proactive approach to your health.

Learn more about Caris Detect and order through the Everlywell platform at https://www.carislifesciences.com/carisdetect/

Caris Life Sciences announced the publication of a study in Cancer Research Communications demonstrating the ability of ...
08/06/2026

Caris Life Sciences announced the publication of a study in Cancer Research Communications demonstrating the ability of a multimodal, multitask deep learning model to estimate late distant recurrence risk in hormone receptor-positive (HR+) early breast cancer.

“By integrating AI-powered analysis of standard pathology images with clinical variables, this approach offers a promising path toward more precise risk stratification and may help inform individualized decisions regarding extended endocrine therapy for patients with hormone receptor-positive breast cancer,” said George W. Sledge, MD, Chief Medical Officer.

Learn more: https://ow.ly/1PaV50ZwOr2

Today we reported revenue growth of 45% driven by strong performance in molecular profiling services, including approxim...
08/05/2026

Today we reported revenue growth of 45% driven by strong performance in molecular profiling services, including approximately 59,200 clinical cases, consisting of over 114,000 whole exome/whole transcriptome tests with over 345,000 total oncology tests.

We also raised our 2026 revenue guidance to $1.03 to $1.04 billion, representing growth of 27% to 28%.

Learn more: https://ow.ly/3URc50ZwME3

This World Lung Cancer Day, Caris is helping bring more complete answers to lung cancer care. Many patients receive some...
08/01/2026

This World Lung Cancer Day, Caris is helping bring more complete answers to lung cancer care.

Many patients receive some biomarker testing, but not all tests provide the full picture, which can impact treatment decisions and outcomes. Comprehensive molecular profiling helps ensure important information is not missed.

Learn more about how Caris testing supports lung cancer care: https://ow.ly/MMhV50ZtQc0

07/31/2026

When Daniel Mortensen, MD, was diagnosed with Stage IV cancer, he faced uncertainty not only as a physician, but also as a husband and father. Biomarker testing helped provide the clarity his care team needed to guide treatment — and gave Daniel more time to be present for the moments that matter most.

In the second story in our “Behind the Diagnosis” series, read Daniel’s powerful story of hope, family and finding answers. https://bit.ly/4yQRO9O

07/29/2026

A blood sample can provide important information at different points in cancer care. The Caris Blood Lab supports Caris Assure® and Caris Detect™. Watch the lab tour to see how blood-based testing can help uncover meaningful insights: https://bit.ly/4x9vjvg

For many patients, uncertainty after a breast cancer diagnosis can feel overwhelming. Caris MI Clarity™ is designed to b...
07/27/2026

For many patients, uncertainty after a breast cancer diagnosis can feel overwhelming.

Caris MI Clarity™ is designed to bring greater clarity by assessing both early and late distant recurrence risk from a single test at diagnosis.

Ask your care team about MI Clarity today: https://ow.ly/BFMY50ZruOb

Every patient deserves clarity and confidence throughout their cancer journey. Caris offers molecular insights that help...
07/24/2026

Every patient deserves clarity and confidence throughout their cancer journey. Caris offers molecular insights that help you and your oncologist personalize treatment decisions and explore the options that fit your needs. Ask your physician about Caris testing. Learn more: https://ow.ly/oKTY50Zsp1v

What if a blood test could help your doctor learn more about your cancer? Caris Assure® a blood-based test that analyzes...
07/23/2026

What if a blood test could help your doctor learn more about your cancer?

Caris Assure® a blood-based test that analyzes biomarkers when tissue samples are unavailable, provides physicians with important molecular insights that can support more informed treatment decisions.

Talk to your care team to learn whether molecular profiling may be right for you. https://ow.ly/Gsya50ZnWuj

Address

-
Irving, TX
75039

Opening Hours

Monday 7am - 7pm
Tuesday 7am - 7pm
Wednesday 7am - 7pm
Thursday 7am - 7pm
Friday 7am - 7pm

Telephone

+18889798669

Website

Alerts

Be the first to know and let us send you an email when Caris Life Sciences posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Category